Nucleic acid molecules encoding a humanized antibody
US8796439B2 · kind B2 · utility
10Cited by
106References
47Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 7, 2012 |
| Grant date | Aug 5, 2014 |
| Priority date | — |
| Expiry date | Aug 7, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to chimeric and humanized antibody and to methods and compositions for the therapeutic and diagnostic use in the treatment of amyloidosis, a group of disorders and abnormalities associated with amyloid protein such as Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.